NCT00998972View on ClinicalTrials.gov

N-acetyl-cysteine (NAC) and Kidney Graft Function

PHASE3CompletedINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2010

Study Completion Date

June 30, 2011

Conditions
Brain DeathChronic Renal Insufficiency
Interventions
DRUG

N-acetylcysteine

600 mg intravenous before and 2 hours after cerebral arteriography

Trial Locations (1)

06000

CHU de Nice, Nice

All Listed Sponsors
lead

Institut d'Anesthesiologie des Alpes Maritimes

OTHER

NCT00998972 - N-acetyl-cysteine (NAC) and Kidney Graft Function | Biotech Hunter | Biotech Hunter